Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL655P is a pseudogene formed from the duplication and integration of sequences derived from the 7SL RNA gene. The 7SL RNA encodes the RNA portion of the signal recognition particle, which is involved in the co-translational translocation of proteins across the endoplasmic reticulum membrane[3][4][5][6]. Pseudogenes like RN7SL655P are truncated or mutated copies of the ancestral gene lacking biological activity, do not code for functional RNAs, and are generally not expressed[4][5][6]. Most such pseudogenes are present in the genome as molecular fossils resulting from reverse transcription events and do not participate in cellular signaling, transformation, or therapeutic interactions[4][5][6].
None. No drugs target pseudogenes of this class
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 655, pseudogene (RN7SL655P).